UNAUDITED PRO FORMA FINANCIAL INFORMATIONUnaudited Pro Forma Financial Information • October 23rd, 2023 • Icad Inc • Surgical & medical instruments & apparatus
On October 22, 2023, iCAD, Inc. (the “Company”), entered into an Asset Purchase Agreement (the “Purchase Agreement”), by and among (i) the Company, Xoft Solutions, LLC, a Delaware limited liability company, and Xoft, Inc., a Delaware corporation, each a wholly owned subsidiary of the Company (collectively with the Company, the “Sellers” and each, a “Seller”), and (ii) Elekta Inc., a Georgia corporation, and Nucletron Operations B.V., a company organized under the laws of the Netherlands (together, “Buyers” and each a “Buyer”), pursuant to which the Company agreed to transfer to the Buyers substantially all of the assets and liabilities primarily related to the Company’s Xoft business lines (the “Business”), including with respect to employees, contracts, intellectual property and inventory, for a cash payment of approximately $5.76 million dollars from the Buyers to the Company.
ASSET PURCHASE AGREEMENT by and between ELEKTA INC., NUCLETRON OPERATIONS B.V., ICAD, INC., XOFT, INC. and XOFT SOLUTIONS, LLC Dated as of October 22, 2023Asset Purchase Agreement • October 23rd, 2023 • Icad Inc • Surgical & medical instruments & apparatus • Delaware
This asset purchase agreement (this “Agreement”) is made as of October 22, 2023, by and among (i) iCAD, Inc., a Delaware corporation, Xoft Solutions, LLC, a Delaware limited liability company, and Xoft, Inc., a Delaware corporation (collectively, “Sellers” and each a “Seller”), and (ii) Elekta Inc., a Georgia corporation, and Nucletron Operations B.V., a company organized under the laws of the Netherlands (together, “Buyers” and each a “Buyer”). Except as otherwise set forth herein, capitalized terms used herein have the meanings set forth in Exhibit A.
